Safety and Performance Study of the Reliance 4-Front Lead

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 167 participants.

Also called NCT01772576

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 167 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01772576
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, China, Denmark, France, Germany, Israel, Italy, Portugal, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01772576. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-06 (actual). Results posted on 2017-06-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Performance Study of the Reliance 4-Front Lead
Condition
Tachycardia
Intervention (Device)
Reliance 4-Front lead implantation
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01772576
Content hash
f94d87572309cb4533bde82b0e4b388a6b95572cc39ba27c952bd77d5be4afc5